POWCS HDR student Emily He was awarded the inaugural White-Walker Cancer Research (Oxford) Scholarship, working in Oxford in 2016/17. Whilst at Oxford, Emily attended the World Cancer Congress in Paris.
Emily describes her scholarship experience below:
POWCS is pleased to announce that Chris Pardy, from UNSW Stats Central, will be working in the school (Lowy level 2) one day per week on Tuesdays offering free design and analysis advice to POWCS HDR and ILP students and staff*.
Congratulations to Emma Devenney who was recently awarded the Dean's Award for Rising Star PhD student.
The Media Office has advised the School of the top 10 research stories for UNSW Medicine in 2016, measured by total Australian audience reach on international and online media.
Research in our School are featured prominently in the list:
#2 Medical scientists develop 'game-changing' stem cell repair system (April, 4.5 million) - John Pimanda and Vashe Chandrakanthan
A new treatment is giving sick kids and their families hope.
Applications are now being accepted for the TCRN Clinical PhD Scholarship Top-up Awards Round 1, 2017.
The Prince of Wales Clinical School held their annual Postgraduate Research Seminar Day on 28 October. 14 students gave oral presentations of their research work, with another 22 students completing a poster. The school was delighted to have Professor Cyndi Shannon Weickert as guest speaker on the day, who also participated as a judge for the oral presentations.
Recently the Australian Physiotherapy Association (APA) ACT Research Symposium was held, on Saturday 10th September at the University of Canberra. The conference is a full day program showcasing current and emerging physiotherapy research from speakers all around Australia.
An exquisite example of research in action, orthopaedic researcher and surgeon Bill Walsh and his team are inventing the biomedical devices of the future.
Professor Bill Walsh is a dynamo. His energy and passion are so vibrant, I swear I can see lightbulbs popping out of his head every few seconds as we talk.
Australian cancer researchers have developed a highly promising technology to deliver gene-silencing drugs to treat pancreatic cancer – the most chemo-resistant and deadly cancer in Australia.
When tested in mice, the new nanomedicine resulted in a 50 per cent reduction in the growth of tumours and reduced the spread of pancreatic cancer.